Beck Mack & Oliver LLC Takes Position in Ryan Specialty Holdings Inc. $RYAN

Beck Mack & Oliver LLC bought a new stake in shares of Ryan Specialty Holdings Inc. (NYSE:RYANFree Report) during the 3rd quarter, Holdings Channel.com reports. The firm bought 50,000 shares of the company’s stock, valued at approximately $2,818,000.

A number of other institutional investors have also recently added to or reduced their stakes in RYAN. Independent Franchise Partners LLP purchased a new position in Ryan Specialty in the third quarter valued at about $95,798,000. Champlain Investment Partners LLC boosted its position in shares of Ryan Specialty by 76.9% in the third quarter. Champlain Investment Partners LLC now owns 3,066,011 shares of the company’s stock worth $172,800,000 after buying an additional 1,332,773 shares during the period. Norges Bank acquired a new stake in shares of Ryan Specialty in the second quarter valued at about $88,305,000. Artisan Partners Limited Partnership acquired a new stake in shares of Ryan Specialty in the second quarter valued at about $64,961,000. Finally, Principal Financial Group Inc. raised its holdings in shares of Ryan Specialty by 21.1% during the 3rd quarter. Principal Financial Group Inc. now owns 4,392,717 shares of the company’s stock valued at $247,576,000 after buying an additional 765,428 shares during the period. 84.82% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. Jefferies Financial Group began coverage on Ryan Specialty in a research report on Monday, December 1st. They set a “hold” rating and a $64.00 price target on the stock. BMO Capital Markets downgraded shares of Ryan Specialty from an “outperform” rating to a “market perform” rating and lowered their price objective for the company from $66.00 to $43.00 in a research report on Wednesday, February 25th. Piper Sandler dropped their price objective on shares of Ryan Specialty from $58.00 to $43.00 and set a “neutral” rating on the stock in a research note on Friday, February 13th. Mizuho reduced their target price on shares of Ryan Specialty from $53.00 to $44.00 and set a “neutral” rating on the stock in a research report on Friday, February 27th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Ryan Specialty from $63.00 to $56.00 and set an “underweight” rating for the company in a research note on Wednesday, January 7th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, five have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, Ryan Specialty has an average rating of “Hold” and an average price target of $56.40.

Get Our Latest Report on Ryan Specialty

Insider Activity

In related news, Director Patrick G. Ryan, Jr. purchased 25,500 shares of the business’s stock in a transaction that occurred on Monday, February 23rd. The shares were purchased at an average cost of $39.96 per share, with a total value of $1,018,980.00. Following the completion of the acquisition, the director directly owned 428,295 shares of the company’s stock, valued at approximately $17,114,668.20. The trade was a 6.33% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 52.21% of the company’s stock.

Ryan Specialty Trading Down 0.0%

Shares of RYAN opened at $36.16 on Friday. Ryan Specialty Holdings Inc. has a one year low of $35.84 and a one year high of $77.16. The stock has a 50-day moving average price of $44.67 and a 200 day moving average price of $51.15. The company has a debt-to-equity ratio of 2.62, a quick ratio of 0.98 and a current ratio of 0.98. The company has a market capitalization of $9.55 billion, a P/E ratio of 86.11, a P/E/G ratio of 0.94 and a beta of 0.65.

Ryan Specialty (NYSE:RYANGet Free Report) last posted its quarterly earnings data on Thursday, February 12th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.05). Ryan Specialty had a return on equity of 46.41% and a net margin of 7.02%.The business had revenue of $751.21 million for the quarter, compared to analysts’ expectations of $777.43 million. During the same quarter in the prior year, the firm earned $0.45 earnings per share. Ryan Specialty’s revenue for the quarter was up 13.2% compared to the same quarter last year. Sell-side analysts forecast that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 10th. Investors of record on Tuesday, February 24th were paid a $0.13 dividend. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.4%. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.12. The ex-dividend date was Tuesday, February 24th. Ryan Specialty’s payout ratio is presently 123.81%.

Ryan Specialty Profile

(Free Report)

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.

Recommended Stories

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYANFree Report).

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.